v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 3 Months Ended
Mar. 31, 2025
Accounting Policies [Abstract]  
SCHEDULES OF CONCENTRATION OF RISK, BY RISK FACTOR

Following is a summary of customers who accounted for more than ten percent (10%) of the Company’s revenues for the three months ended March 31, 2025, and 2024, and their accounts receivable balance as of March 31, 2025:

 

   Sales % Three Months Ended March 31, 2025    Sales % Three Months Ended March 31, 2024   Accounts receivable balance March 31, 2025 
Customer A   44%    -   $14,875 
Customer B   28%    -   $- 
Customer C   20%    67%  $7,200 
Customer D   -     10%  $- 
SCHEDULE OF USEFUL LIFE OF PROPERTY AND EQUIPMENT ASSETS

Building   10-25 years
Office furniture and equipment   3-5 years
Warehouse equipment   7 years
SCHEDULE OF DISAGGREGATION OF REVENUE

The following table disaggregates our revenue by major source for the three months ended March 31, 2025, and 2024:

 

   2025   2024 
   Three months ended March 31, 
   2025   2024 
Sourced and distributed products  $3,024   $75,222 
OED Installations   39,233    176,500 
Total  $42,257   $251,722 
SCHEDULE OF DERIVATIVE INSTRUMENTS

The following table represents the Company’s derivative instruments that are measured at fair value on a recurring basis as of March 31, 2025, and December 31, 2024, for each fair value hierarchy level:

 

March 31, 2025  Derivative Liabilities   Total 
Level I  $-   $- 
Level II  $-   $- 
Level III  $98,734   $98,734 

 

December 31, 2024  Derivative Liabilities   Total 
Level I  $-   $- 
Level II  $-   $- 
Level III  $210,493   $210,493 
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE
   March 31,
2025		   March 31,
2024		 
Convertible preferred stock (1)   12,329,766,446    8,732,725,692 
Unexercised common stock purchase warrants (1)   732,024,518    807,024,518 
Convertible notes payable (1)   471,429,292    72,738,215 
Promissory notes payable (1)   7,577,465,753    667,746,575 
Total   21,110,686,009    10,280,235,000 

 

(1) The potentially dilutive shares included in the above table are limited whereby the conversion or exercise cannot result in the beneficial owner holding more than 4.99% of the then outstanding shares of common stock subsequent to any conversion or exercise. These shares were excluded from the diluted per share calculation because the effect of including these potential shares was anti-dilutive due to the Company’s net loss position.